- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06354517
The Impact of the SENSE Program on NICU
April 8, 2024 updated by: Mujde CALIKUSU INCEKAR, Yuksek Ihtisas University
The Impact of the SENSE Program on Parent and Newborn
The SENSE program will be applied to babies receiving treatment in the neonatal intensive care unit and the effect of the application on the baby and parents will be examined.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
For the growth and health of the baby, the intrauterine environment provides the fetus with protective physical barriers and sensory exposures timed appropriately for its development.
These early exposures occur during sensory development in the intrauterine environment, and there are differences in the timing of development of each sense.
When the baby is born prematurely, the intrauterine environment is replaced by the Neonatal Intensive Care Unit environment.
The sensory environment of the preterm baby includes the experiences of touch, movement, smell, sound, light, frequent nociceptive pain and disruption of sleep.
The mismatch between the infant's underdeveloped coping skills and the stimulating NICU environment can cause physiological imbalance, negatively impact growth and development, and ultimately predispose to the development of long-term neurodevelopmental consequences.
Although harmful sensory exposures can negatively affect the development of the preterm baby, appropriate positive sensory exposures positively affect brain development.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Müjde ÇALIKUŞU İNCEKAR, PhD
- Phone Number: 0905547860346
- Email: mujdecalikusu@gmail.com
Study Locations
-
-
-
Ankara, Turkey
- Yuksek Ihtisas University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being in the first week of life
Exclusion Criteria:
- Congenital anomaly,
- Preterm babies who are not predicted to survive,
- Babies who cannot be followed regularly,
- Parent having a psychiatric problem
- Parents who wish to withdraw from the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SENSE group
Parents of babies in this group will be given SENSE program training.
After the training, parents will care for their babies within the scope of the SENSE program.
These babies will receive care from their parents with positive sensory exposures within the scope of the SENSE program from admission to the clinic until discharge.
Data collection forms will be administered to babies and their parents.
|
Parents of babies in this group will be given SENSE program training.
After the training, parents will care for their babies within the scope of the SENSE program.
These babies will receive care from their parents with positive sensory exposures within the scope of the SENSE program from admission to the clinic until discharge.
Data collection forms will be administered to babies and their parents.
|
|
No Intervention: Control group
The SENSE program will not be applied to the parents of babies in this group.
These babies will receive the routine care of the clinic.
These babies will be monitored from admission to the clinic until discharge.
Data collection forms will be administered to infants and parents.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hammersmıth Neonatal Neurologıcal Examınatıon
Time Frame: 24 hours
|
It will be applied twice: when the baby is first admitted to the clinic and before discharge.
|
24 hours
|
|
Parental Stress Scale: Neonatal Intensive Care Unit
Time Frame: 24 hours
|
It will be applied twice: when the baby is first admitted to the clinic and before discharge.
|
24 hours
|
|
State-trait Anxiety Inventory
Time Frame: 24 hours
|
It will be applied twice: when the baby is first admitted to the clinic and before discharge.
|
24 hours
|
|
Edinburgh Postnatal Depression Scale
Time Frame: 24 hours
|
It will be applied twice: when the baby is first admitted to the clinic and before discharge.
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sevim SAVAŞER, PhD, Biruni University
- Principal Investigator: Ahu ÇIRLAK, PhD, Ankara Güven Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
May 30, 2025
Study Completion (Estimated)
May 30, 2025
Study Registration Dates
First Submitted
March 29, 2024
First Submitted That Met QC Criteria
April 8, 2024
First Posted (Actual)
April 9, 2024
Study Record Updates
Last Update Posted (Actual)
April 9, 2024
Last Update Submitted That Met QC Criteria
April 8, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YIU-M-CI-003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre-Term
-
Stanford UniversityNot yet recruiting
-
SABA AL-SULTTANCompletedPre-oxygenation in Term Pregnant WomenUnited Kingdom
-
District Headquarters Teaching Hospital SahiwalCompletedPre-term Premature Rupture of MembranesPakistan
-
Abbott NutritionCompletedPre-term InfantsUnited States
-
Monica Healthcare LtdNew York Presbyterian HospitalTerminatedMultiple Pregnancy | Pre Term LaborUnited States
-
Assiut UniversityNot yet recruitingFeeding; Difficult, Newborn | Pre-Term
-
Azienda Ospedaliera Universitaria Policlinico "G...CompletedOxidative Stress | Newborn Morbidity | Pre-Term | Melatonin DeficiencyItaly
-
Imperial College Healthcare NHS TrustRecruitingPre-TermUnited Kingdom
Clinical Trials on SENSE group
-
Hacettepe UniversityCompleted
-
Washington State UniversityNational Institute of Nursing Research (NINR)Completed
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Sense Diagnostics, LLCCongressionally Directed Medical Research ProgramsRecruitingTraumatic Brain InjuryUnited States
-
IceCure Medical Ltd.CompletedFibroadenomaCzechia, Germany, Israel
-
Sense Diagnostics, LLCCompletedStroke, Acute | Stroke Hemorrhagic | Intracerebral HemorrhageUnited States
-
Common SenseWithdrawn
-
Common SenseCompletedAMNIOTIC FLUID LEAKAGE
-
Common SenseUnknownPreterm Birth | Bacterial Vaginosis | Vaginal Infections | Preterm Premature Rupture of Membranes | Late MiscarriageIsrael